Skip to main content
Fund RaisingNewsPress ReleasesResearch

Press Release: Partnering on Innovative Lung Cancer Research

By May 31, 2022April 2nd, 2024No Comments

The Happy Lungs Project is pleased to share research that we are funding in collaboration with our sister organizations, RETpositive and Lungevity.

Original article:

RET-positive lung cancer community funds research into critical areas of need


Patient group RETpositive and LUNGevity Foundation today announced the 2022 recipients of the first RETpositive/LUNGevity Translational Research Award for RET-Positive Lung Cancer. RET is a driver mutation found in approximately 1%-2% of people with non-small cell lung cancer. The goal of these awards is to transform the future for those diagnosed with RET-positive lung cancer by changing RET-positive lung cancer into a chronic or curable condition. These awards total $100,000 each for a two-year term. Funds were raised by RETpositive, a patient-driven nonprofit that aims to improve the quality of life and life expectancy of RET-positive cancer patients.

Read more of the article